Advances in diagnosis, treatment and prognostic factors of gastrointestinal DLBCL
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in diagnosis, treatment and prognostic factors of gastrointestinal DLBCL
Authors
Keywords
-
Journal
LEUKEMIA RESEARCH
Volume -, Issue -, Pages 107406
Publisher
Elsevier BV
Online
2023-10-18
DOI
10.1016/j.leukres.2023.107406
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognosis and complications of patients with primary gastrointestinal diffuse large B‐cell lymphoma: Development and validation of the systemic inflammation response index‐covered score
- (2023) Yurou Chu et al. Cancer Medicine
- Prognostic effects of clinical parameters, genetic abnormalities, and subtypes in primary gastric diffuse large B-cell lymphoma: a cohort analysis of 146 patients
- (2022) Junqing Liu et al. LEUKEMIA & LYMPHOMA
- Clinical Features Analysis and Survival Nomogram of Primary Small Intestinal Diffuse Large B-Cell Lymphoma
- (2022) Xiaohong Liu et al. Cancer Management and Research
- Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma
- (2022) Shan-Shan Li et al. Experimental Hematology & Oncology
- Stage I DLBCL: extranodal may mean extra radiation
- (2021) Izidore S. Lossos BLOOD
- Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma
- (2021) Do Young Kim et al. Cancer Research and Treatment
- Increased MALAT1 expression predicts poor prognosis in primary gastrointestinal diffuse large B-cell lymphoma
- (2021) Zhengzi Qian et al. CLINICAL AND EXPERIMENTAL MEDICINE
- 18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma
- (2021) Jakoba J. Eertink et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The relationship among primary anatomic subsite and risk and distribution of second malignant neoplasms in patients with stage I/II diffuse large B-cell lymphoma: An analysis of the surveillance, epidemiology, and end results database
- (2021) Xuejiao Yin et al. Translational Oncology
- A Prognostic Model of Gastrointestinal Diffuse Large B Cell Lymphoma
- (2021) Fan Gao et al. MEDICAL SCIENCE MONITOR
- Epstein-Barr Virus Positive B-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
- (2021) Eri Ishikawa et al. Cancers
- Clinical Features and Prognostic Significance of NOTCH1 Mutations in Diffuse Large B-Cell Lymphoma
- (2021) Zhongqi Li et al. Frontiers in Oncology
- International prognostic indices in diffuse large B-cell lymphoma (DLBCL): a comparison of IPI, R-IPI and NCCN-IPI
- (2020) Amy S Ruppert et al. BLOOD
- Texture Analysis Improves the Value of Pretreatment 18F-FDG PET/CT in Predicting Interim Response of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
- (2020) Yiwen Sun et al. Contrast Media & Molecular Imaging
- Pattern of failure and optimal treatment strategy for primary gastric diffuse large B-cell lymphoma treated with R-CHOP chemotherapy
- (2020) Hye Jin Kang et al. PLoS One
- Differentiating gastric cancer and gastric lymphoma using texture analysis (TA) of positron emission tomography (PET)
- (2020) Yi-Wen Sun et al. CHINESE MEDICAL JOURNAL
- Will Baseline Total Lesion Glycolysis Play a Role in Improving the Prognostic Value of the NCCN-IPI in Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated With the R-CHOP Regimen?
- (2020) Chong Jiang et al. CLINICAL NUCLEAR MEDICINE
- The Impact of Surgery on Long-Term Survival of Patients with Primary Gastric Diffuse Large B-Cell Lymphoma: A SEER Population-Based Study
- (2019) Ju-Li Lin et al. Gastroenterology Research and Practice
- Primary Diffuse Large B-Cell Lymphoma of the Descending Colon
- (2019) Bashar Sharma et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Surgical management of primary colonic lymphoma: Big data for a rare problem
- (2019) Lillias H. Maguire et al. JOURNAL OF SURGICAL ONCOLOGY
- Dynamic prediction of long-term survival in patients with primary gastric diffuse large B-cell lymphoma: a SEER population-based study
- (2019) Ju-Li Lin et al. BMC CANCER
- Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphoma
- (2019) Eri Ishikawa et al. JOURNAL OF GASTROENTEROLOGY
- Gastrointestinal non-Hodgkin lymphomas
- (2019) Magdalena Olszewska-Szopa et al. Advances in Clinical and Experimental Medicine
- Primary Pediatric Non-Hodgkin Lymphomas of the Gastrointestinal Tract: A Population-based Analysis
- (2019) BURIA NAEEM et al. ANTICANCER RESEARCH
- Intralymphatic Spread is a Rare Finding Associated With Poor Prognosis in Diffuse Large B-Cell Lymphoma With Extranodal Involvements
- (2018) Chieh-Lung Cheng et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The clinical manifestation, survival outcome and predictive prognostic factors of 137 patients with primary gastrointestinal lymphoma (PGIL)
- (2018) Zhan Shi et al. MEDICINE
- Expression of programmed cell death 1/programmed cell death ligand 1 in the tumor microenvironments of primary gastrointestinal diffuse large B cell lymphomas
- (2018) Yang Liu et al. PATHOLOGY RESEARCH AND PRACTICE
- Incidence Rate, Subtype Frequency, and Occurrence Site of Malignant Lymphoma in the Gastrointestinal Tract: Population-Based Analysis in Miyagi, Japan
- (2018) Fumiyoshi Fujishima et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- A prognostic model, including the EBV status of tumor cells, for primary gastric diffuse large B-cell lymphoma in the rituximab era
- (2018) Eri Ishikawa et al. Cancer Medicine
- Secondary skin involvement in gastric diffuse large B-cell lymphoma treated with chidamide
- (2018) Dan Yang et al. MEDICINE
- EZH2 overexpression in primary gastrointestinal diffuse large B-cell lymphoma and its association with the clinicopathological features
- (2017) Yang Liu et al. HUMAN PATHOLOGY
- Primary appendiceal lymphoma: clinical characteristics and outcomes of 116 patients
- (2017) Adil Ayub et al. JOURNAL OF SURGICAL RESEARCH
- Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy
- (2017) Z Yao et al. LEUKEMIA
- Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma
- (2016) Kohei Taniguchi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- MYD88,CD79B, andCARD11gene mutations in CD5-positive diffuse large B-cell lymphoma
- (2016) Toshifumi Takeuchi et al. CANCER
- Mad2 overexpression is associated with high cell proliferation and reduced disease-free survival in primary gastrointestinal diffuse large B-cell lymphoma
- (2016) Fei Chen et al. Hematology
- Management of Primary Gastrointestinal Non-Hodgkin Lymphomas: a Population-Based Survival Analysis
- (2016) Evan Michael Shannon et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Diffuse Large B-Cell Lymphoma Version 1.2016
- (2016) Andrew D. Zelenetz et al. Journal of the National Comprehensive Cancer Network
- Clinicopathological features of 49 primary gastrointestinal diffuse large B-cell lymphoma cases; comparison with location, cell-of-origin, and frequency of MYD88 L265P
- (2016) Keina Nagakita et al. PATHOLOGY INTERNATIONAL
- Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma
- (2016) Zheng Ge et al. World Journal of Surgical Oncology
- The role of surgical intervention in primary colorectal lymphoma: A SEER population-based analysis
- (2016) Yi-bo Cai et al. Oncotarget
- Primary Intestinal Diffuse Large B-cell Lymphoma in Taiwan Showed a Relative Higher Rate of Perforation and EBV Association
- (2016) Yi-Hsuan Lu et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma
- (2015) Tarec Christoffer El-Galaly et al. AMERICAN JOURNAL OF HEMATOLOGY
- Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
- (2015) J. Kiyasu et al. BLOOD
- Primary Gastrointestinal Non-Hodgkin’s Lymphoma of the Small and Large Intestines: a Systematic Review
- (2015) Amy L. Lightner et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Safety and efficacy of low-dose pre-phase before conventional-dose chemotherapy for ulcerative gastric diffuse large B-cell lymphoma
- (2015) Yingying Cui et al. LEUKEMIA & LYMPHOMA
- Coexpression ofMYCandBCL-2predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma
- (2015) Bing Xia WORLD JOURNAL OF GASTROENTEROLOGY
- Localized primary gastrointestinal diffuse large B cell lymphoma received a surgical approach: an analysis of prognostic factors and comparison of staging systems in 101 patients from a single institution
- (2015) Shengting Zhang et al. World Journal of Surgical Oncology
- Overexpression of DNA methyltransferase 1 as a negative independent prognostic factor in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab
- (2015) HAIFENG ZHAO et al. Oncology Letters
- Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era
- (2014) R. Vaidya et al. ANNALS OF ONCOLOGY
- Prevalence and Clinical Implications of Epstein-Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries
- (2014) C. Y. Ok et al. CLINICAL CANCER RESEARCH
- Clinical Efficacy and Safety in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Literature Review
- (2014) Ann Colosia et al. Clinical Lymphoma Myeloma & Leukemia
- Intestinal Diffuse Large B-Cell Lymphoma: An Evaluation of Different Staging Systems
- (2014) Hee Sang Hwang et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Downregulated expression of Dicer1 predicts inferior survival in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab
- (2014) Haifeng Zhao et al. MEDICAL ONCOLOGY
- Endoscopic features of gastro-intestinal lymphomas: From diagnosis to follow-up
- (2014) Calogero Vetro WORLD JOURNAL OF GASTROENTEROLOGY
- Clinicopathological analysis and prognostic factors of 11 patients with primary non-Hodgkin lymphoma of the small intestine in a single institute
- (2014) JIA-HONG CHEN et al. Oncology Letters
- Bowel perforation in intestinal lymphoma: incidence and clinical features
- (2013) R. Vaidya et al. ANNALS OF ONCOLOGY
- Increased Expression of the Spindle Checkpoint Protein BubR1 is Associated with High Cell Proliferation in Primary Gastrointestinal Diffuse Large B Cell Lymphoma
- (2013) Fei Chen et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Detection of human JCPyV and BKPyV in diffuse large B-cell lymphoma of the GI tract
- (2013) C. E. Tseng et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi
- (2013) A. Chiappella et al. HAEMATOLOGICA
- High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites
- (2013) W Kraan et al. Blood Cancer Journal
- The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma
- (2012) Byeong Seok Sohn et al. ANNALS OF HEMATOLOGY
- Treatment of gastrointestinal diffuse large B cell lymphoma in China: a 10-year retrospective study of 114 cases
- (2012) Xiaoyang Li et al. ANNALS OF HEMATOLOGY
- Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) H. Tilly et al. ANNALS OF ONCOLOGY
- Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial
- (2012) A. J. M. Ferreri et al. BLOOD
- Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis
- (2012) Sugama Chicklore et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Bcl-6 expression and lactate dehydrogenase level predict prognosis of primary gastric diffuse large B-cell lymphoma
- (2012) Kun-Ming Chung et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan
- (2011) Tsutomu Tanaka et al. ANNALS OF HEMATOLOGY
- Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older
- (2011) Akiko Meguro et al. LEUKEMIA & LYMPHOMA
- Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone
- (2010) S. J. Kim et al. BLOOD
- Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
- (2010) B. Coiffier et al. BLOOD
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
- (2010) Christian Gisselbrecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Relevance of the International Prognostic Index in the Rituximab Era
- (2010) Kevin Tay et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
- (2009) Mara Compagno et al. NATURE
- High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin’s lymphoma
- (2008) Ming-Huang Chen et al. ANNALS OF HEMATOLOGY
- Perforation predicts poor prognosis in patients with primary intestinal diffuse large B-cell lymphoma
- (2008) S-S Chuang et al. HISTOPATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started